Opens up new avenues of research into thousands of similar molecules, many of which are likely to be medically useful.
Researchers report in the journal Nature that they have made a breakthrough in understanding how a powerful antibiotic agent is made in nature. Their discovery solves a decades-old mystery, and opens up new avenues of research into thousands of similar molecules, many of which are likely to be medically useful.
The team focused on a class of compounds that includes dozens with antibiotic properties. The most famous of these is nisin, a natural product in milk that can be synthesized in the lab and is added to foods as a preservative. Nisin has been used to combat food-borne pathogens since the late 1960s.
Researchers have long known the sequence of the nisin gene, and they can assemble the chain of amino acids (called a peptide) that are encoded by this gene. But the peptide undergoes several modifications in the cell after it is made, changes that give it its final form and function. Researchers have tried for more than 25 years to understand how these changes occur.
“Peptides are a little bit like spaghetti; they’re too flexible to do their jobs,” said University of Illinois chemistry professor Wilfred van der Donk, who led the research with biochemistry professor Satish K. Nair. “So what nature does is it starts putting knobs in, or starts making the peptide cyclical.”
Special enzymes do this work. For nisin, an enzyme called a dehydratase removes water to help give the antibiotic its final, three-dimensional shape. This is the first step in converting the spaghetti-like peptide into a five-ringed structure, van der Donk said.
The rings are essential to nisin’s antibiotic function: Two of them disrupt the construction of bacterial cell walls, while the other three punch holes in bacterial membranes. This dual action is especially effective, making it much more difficult for microbes to evolve resistance to the antibiotic.
Previous studies showed that the dehydratase was involved in making these modifications, but researchers have been unable to determine how it did so. This lack of insight has prevented the discovery, production and study of dozens of similar compounds that also could be useful in fighting food-borne diseases or dangerous microbial infections, van der Donk said.
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- PSU drugmaker Hindustan Antibiotics hopes to regain health post ₹250-crore VRS on June 19, 2019 at 9:38 am
Hindustan Antibiotics Ltd, a Pune-based maker of penicillin and other pharma products, is pinning its hopes on a ₹250-crore Voluntary Retirement Scheme (VRS) for a quick turnaround. Under the scheme, ... […]
- Animal Antibiotics and Antimicrobials Market Overview: on June 19, 2019 at 6:50 am
Animal antibiotics and antimicrobials are used to treat the husbandry of livestock when they are found ill, or any one of them is suffering in a herd to prevent further spreading of the disease. These ... […]
- Pact with Hindustan Antibiotics will help increase product reach: Dinesh Likhi, Mishra Dhatu Nigam on June 19, 2019 at 12:47 am
Dinesh Likhi, CMD at Mishra Dhatu Nigam, talks about the company’s partnership with Hindustan Antibiotics and how the move will increase the reach of the firm’s products. Likhi says the co’s ... […]
- CAGR Of 35.70% | Biosimilar Monoclonal Antibiotics Market Expected To Hike In CAGR From 2017-2026 on June 18, 2019 at 4:21 am
Jun 18, 2019 (WiredRelease via COMTEX) -- A latest detailed analysis titled Biosimilar Monoclonal Antibiotics Market: Worldwide Industry Study and Opportunity Appraisal of Biosimilar Monoclonal ... […]
- Deadly Superbugs Win as Wall Street Flees Makers of Antibiotics on June 17, 2019 at 8:00 am
Four years ago, antibiotics developer Tetraphase Pharmaceuticals Inc. had a market value of almost $2 billion. Now its shares trade for about 70 cents as investors flee the market for new drugs that ... […]
- Fish Farms Face Threats To Growth Prospects From Climate Change And Antibiotics Overuse on June 17, 2019 at 7:05 am
Fish farming is big business – the global aquaculture sector is worth $232 billion – and well placed to profit from global megatrends such as climate change, the growing population and the growing ... […]
- CAGR of over 35.70% By 2026 | Biosimilar Monoclonal Antibiotics Market Was Valued over US$ 1,516.9 Mn in 2016 on June 17, 2019 at 2:04 am
Jun 17, 2019 (WiredRelease via COMTEX) -- The global Biosimilar Monoclonal Antibiotics market was valued over US$ 1,516.9 Mn in 2016, and is expected to register a CAGR of over 35.70%. The report ... […]
- If we want antibiotics to work, consumers have to put big pressure on factory farms on June 16, 2019 at 10:41 am
On March 1, Denny’s stopped purchasing chicken treated with medically important antibiotics for its U.S. restaurants. Many consumers might expect to see such promises at Whole Foods or their local ... […]
- Many of the world’s rivers are flush with dangerous levels of antibiotics on June 14, 2019 at 6:16 am
In a massive survey of rivers across 72 countries, researchers found antibiotics at 66 percent of 711 sites sampled. Many of the most drug-polluted waterways were in Asia and Africa, where there ... […]
- Scientists are putting antibiotics into the ocean—on purpose. And it's our only hope. on June 12, 2019 at 5:27 am
Struggling crops. Salty aquifers. Invading wildlife. Piles of dead fish. The Sunshine State feels the squeeze of environmental change on its beaches, farms, wetlands, and cities. But what afflicts the ... […]
via Bing News